“Estimating the Cost-Effectiveness of Treatment for Prevention of Thromboembolic Events in at-Risk Adults With Non-Valvular Atrial Fibrillation”. 2018. Farmeconomia. Health Economics and Therapeutic Pathways 19 (1). https://doi.org/10.7175/fe.v19i1.1346.